Cello World Limited's board has approved a ₹600 crore capital restructuring for subsidiary CCPL, involving ₹500 crore loan-to-equity conversion and ₹100 crore fresh capital infusion. CCPL, established in 2021, manufactures consumerware products and has grown from nil turnover to ₹18.95 crore by March 2025. The funds will support manufacturing expansion, working capital, and corporate purposes at the Falna facility, with completion expected within three months.
Cello World Limited Approves ₹600 Crore Capital Restructuring for Subsidiary CCPL
Cello World Limited has announced a significant capital restructuring initiative for its wholly owned subsidiary, with the Board of Directors approving a comprehensive financial reorganization plan on February 14, 2026. The restructuring forms part of the company's internal capital optimization strategy and involves substantial financial commitments totaling ₹600 crore.
Board Approval and Transaction Structure
The Board of Directors has authorized two key components of the restructuring plan. The primary element involves converting pre-existing inter-company loans aggregating to ₹500 crore into equity shares of Cello Consumerware Private Limited (CCPL). Additionally, the board has approved a fresh capital infusion of ₹100 crore into the subsidiary through cash investment.
Transaction Component Amount Method Loan Conversion ₹500 crore Inter-company loan to equity Fresh Capital ₹100 crore Cash infusion Total Investment ₹600 crore Combined restructuring
Subsidiary Performance and Background
CCPL, incorporated on December 10, 2021, operates as a wholly owned subsidiary engaged in manufacturing and selling consumerware and consumer durable items. The company has demonstrated significant growth trajectory since its establishment, particularly in steel and glass consumerware products manufactured at its facility in Falna, Rajasthan.
Financial Year Turnover March 31, 2025 ₹18.95 crore March 31, 2024 ₹0.40 crore March 31, 2023 NIL
Share Issuance and Valuation Details
As part of the restructuring, CCPL will issue 48,592 equity shares with a face value of ₹10 each at a premium. The pricing structure is based on valuation recommendations from an independent Registered Valuer, as per the valuation report dated February 02, 2026. The transaction maintains CCPL's status as a 100% wholly owned subsidiary, with no changes to the percentage of shareholding or control structure.
Fund Utilization and Strategic Objectives
The converted loan funds have been previously utilized for establishing the manufacturing unit and providing working capital for steel and glass consumerware products at the Falna facility. The fresh capital infusion of ₹100 crore will support multiple strategic objectives including capital expenditure for the manufacturing unit, working capital requirements, business funding needs, loan repayments, and other general corporate purposes.
Regulatory Compliance and Timeline
The transaction qualifies as a Related Party Transaction conducted on an arm's length basis, with certain directors of Cello World Limited also serving on CCPL's board. The conversion of loan into equity and the fresh capital infusion are scheduled for completion within three months. The company has fulfilled its disclosure obligations under Regulation 30 of SEBI Listing Regulations and made the information available on its corporate website.
Cello World Limited has reported the utilization status of its Rs. 737.32 crore Qualified Institutional Placement (QIP) proceeds through a monitoring agency report prepared by CARE Ratings Limited for the quarter ended December 31, 2025. The consumer durables company, operating in the houseware segment, conducted its QIP issue from July 03-05, 2024.
QIP Proceeds Utilization Overview
The monitoring report reveals that out of the total QIP proceeds of Rs. 737.32 crore, the company has utilized Rs. 694.96 crore across seven defined objects, leaving Rs. 42.36 crore unutilized as of December 31, 2025. During the quarter ended December 31, 2025, the company utilized Rs. 19.15 crore specifically towards Object 1 - investment in subsidiary Cello Consumerware Private Limited.
Utilization Status: Amount (Rs. Crore) Total QIP Proceeds: 737.32 Amount Utilized: 694.96 Unutilized Amount: 42.36 Q3 FY26 Utilization: 19.15
Object-wise Deployment Status
The QIP proceeds were allocated across seven specific objects, with varying degrees of completion. Five objects have been fully completed, while one remains partially implemented due to timeline extensions.
Object: Allocated (Rs. Crore) Utilized (Rs. Crore) Status Manufacturing Facility Setup: 105.25 62.89 Ongoing Subsidiary Debt Repayment: 236.96 236.96 Completed Company Debt Repayment: 100.00 100.00 Completed Promoter Debt Repayment: 83.05 83.05 Completed Working Capital: 79.80 79.80 Completed General Corporate Purposes: 108.06 108.06 Completed QIP Issue Expenses: 24.20 24.20 Completed
Timeline Extension for Manufacturing Facility
The primary area of concern highlighted in the report relates to Object 1 - investment in subsidiary Cello Consumerware Private Limited for setting up a new manufacturing facility for stainless steel bottles, plastic insulatedware, and household articles. The original completion timeline of March 31, 2025, has been extended to March 2026 through a board resolution passed on May 23, 2025.
The company has invested Rs. 62.89 crore in this object through unsecured loans to its subsidiary, with Rs. 19.15 crore utilized during the quarter ended December 31, 2025. The monitoring agency noted that some transactions involved purchase orders pertaining to previous quarters, and funds were routed through the subsidiary's current account, resulting in comingling with other transactions.
Deployment of Unutilized Funds
The unutilized proceeds of Rs. 42.36 crore have been temporarily invested in money market instruments as permitted under the placement document. The funds are primarily deployed in Tata Liquid Fund - Direct Plan - Growth, with a market value of Rs. 51.29 crore as of December 31, 2025, including accumulated earnings of Rs. 4.16 crore that have been reinvested.
Regulatory Compliance and Monitoring
CARE Ratings Limited, serving as the monitoring agency under SEBI regulations, confirmed no deviation from the stated objects of the QIP issue. The report indicates that all utilization aligns with the offer document requirements, though it notes the delay in Object 1 implementation. The monitoring agency has relied on CA certificates, bank statements, mutual fund statements, and management confirmations for verification of fund utilization.
The company's promoters include Pradeep Ghisulal Rathod, Pankaj Ghisulal Rathod, and Gaurav Pradeep Rathod, and the monitoring arrangement was established through an agreement dated July 03, 2024, coinciding with the QIP issue period.
We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.
Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.